-
1
-
-
0025307050
-
Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients
-
Ben-Mahrez K, Sorokine I, Thierry D, Kawasumi T, Ishii S, Salmon R, Kohiyama M. (1990). Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients. Int J Cancer 46:35-8.
-
(1990)
Int J Cancer
, vol.46
, pp. 35-38
-
-
Ben-Mahrez, K.1
Sorokine, I.2
Thierry, D.3
Kawasumi, T.4
Ishii, S.5
Salmon, R.6
Kohiyama, M.7
-
2
-
-
0035503380
-
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer
-
Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. (2001a). Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 61:7908-12.
-
(2001)
Cancer Res
, vol.61
, pp. 7908-7912
-
-
Brichory, F.1
Beer, D.2
Le Naour, F.3
Giordano, T.4
Hanash, S.5
-
3
-
-
0035859922
-
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer
-
Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. (2001b). An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 98:9824-9.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 9824-9829
-
-
Brichory, F.M.1
Misek, D.E.2
Yim, A.M.3
Krause, M.C.4
Giordano, T.J.5
Beer, D.G.6
Hanash, S.M.7
-
4
-
-
0034894792
-
Serum anti-p53 antibodies in lung cancer: Comparison with established tumor markers
-
Cioffi M, Vietri MT, Gazzerro P, Magnetta R, D'Auria A, Durante A, Nola E, Puca GA, Molinari AM. (2001). Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers. Lung Cancer 33:163-9.
-
(2001)
Lung Cancer
, vol.33
, pp. 163-169
-
-
Cioffi, M.1
Vietri, M.T.2
Gazzerro, P.3
Magnetta, R.4
D'Auria, A.5
Durante, A.6
Nola, E.7
Puca, G.A.8
Molinari, A.M.9
-
5
-
-
0019898801
-
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
-
Crawford LV, Pim DC, Bulbrook RD. (1982). Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30:403-8.
-
(1982)
Int J Cancer
, vol.30
, pp. 403-408
-
-
Crawford, L.V.1
Pim, D.C.2
Bulbrook, R.D.3
-
6
-
-
0030761048
-
Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance
-
Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. (1997). Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 114:339-46.
-
(1997)
J Thorac Cardiovasc Surg
, vol.114
, pp. 339-346
-
-
Dobashi, K.1
Sugio, K.2
Osaki, T.3
Oka, T.4
Yasumoto, K.5
-
7
-
-
0030894182
-
K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
-
Fukuyama Y, Mitsudomi T, Sugio K, Ishida T, Akazawa K, Sugimachi K. (1997). K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer 75:1125-30.
-
(1997)
Br J Cancer
, vol.75
, pp. 1125-1130
-
-
Fukuyama, Y.1
Mitsudomi, T.2
Sugio, K.3
Ishida, T.4
Akazawa, K.5
Sugimachi, K.6
-
8
-
-
33845780561
-
Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum
-
Gonzalez-Gronow M, Cuchacovich M, Llanos C, Urzua C, Gawdi G, Pizzo SV. (2006). Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res 66:11424-31.
-
(2006)
Cancer Res
, vol.66
, pp. 11424-11431
-
-
Gonzalez-Gronow, M.1
Cuchacovich, M.2
Llanos, C.3
Urzua, C.4
Gawdi, G.5
Pizzo, S.V.6
-
9
-
-
13944282066
-
The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer
-
Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, Garcia de Herreros A, Bonilla F, Munoz A. (2005). The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24:1098-103.
-
(2005)
Oncogene
, vol.24
, pp. 1098-1103
-
-
Gonzalez-Sancho, J.M.1
Aguilera, O.2
Garcia, J.M.3
Pendas-Franco, N.4
Pena, C.5
Cal, S.6
Garcia de Herreros, A.7
Bonilla, F.8
Munoz, A.9
-
10
-
-
0033595632
-
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events
-
Jager E, Stockert E, Zidianakis Z, Chen YT, Karbach J, Jager D, Arand M, Ritter G, Old LJ, Knuth A. (1999). Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer 84:506-10.
-
(1999)
Int J Cancer
, vol.84
, pp. 506-510
-
-
Jager, E.1
Stockert, E.2
Zidianakis, Z.3
Chen, Y.T.4
Karbach, J.5
Jager, D.6
Arand, M.7
Ritter, G.8
Old, L.J.9
Knuth, A.10
-
11
-
-
0027136829
-
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
-
Lubin R, Schlichtholz B, Bengoufa D, Zalcman G, Tredaniel J, Hirsch A, de Fromentel CC, Preudhomme C, Fenaux P, Fournier G, Mangin P, Laurent-Puig P, Pelletier G, Schlumberger M, Desgrandchamps F, Le Duc A, Peyrat JP, Janin N, Bressac B, Soussi T et al. (1993). Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. Cancer Res 53:5872-6.
-
(1993)
Cancer Res
, vol.53
, pp. 5872-5876
-
-
Lubin, R.1
Schlichtholz, B.2
Bengoufa, D.3
Zalcman, G.4
Tredaniel, J.5
Hirsch, A.6
de Fromentel, C.C.7
Preudhomme, C.8
Fenaux, P.9
Fournier, G.10
Mangin, P.11
Laurent-Puig, P.12
Pelletier, G.13
Schlumberger, M.14
Desgrandchamps, F.15
Le Duc, A.16
Peyrat, J.P.17
Janin, N.18
Bressac, B.19
Soussi, T.20
more..
-
12
-
-
0029014010
-
Serum p53 antibodies as early markers of lung cancer
-
Lubin R, Zalcman G, Bouchet L, Tredanel J, Legros Y, Cazals D, Hirsch A, Soussi T. (1995). Serum p53 antibodies as early markers of lung cancer. Nat Med 1:701-2.
-
(1995)
Nat Med
, vol.1
, pp. 701-702
-
-
Lubin, R.1
Zalcman, G.2
Bouchet, L.3
Tredanel, J.4
Legros, Y.5
Cazals, D.6
Hirsch, A.7
Soussi, T.8
-
13
-
-
0028811996
-
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
-
Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. (1995). Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120-129.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, pp. 120-129
-
-
Martini, N.1
Bains, M.S.2
Burt, M.E.3
Zakowski, M.F.4
McCormack, P.5
Rusch, V.W.6
Ginsberg, R.J.7
-
14
-
-
0030912190
-
Revisions in the International System for Staging Lung Cancer
-
Mountain CF (1997). Revisions in the International System for Staging Lung Cancer. Chest 111:1710-17.
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
15
-
-
33749502582
-
Autoantibody cancer biomarker: Extracellular protein kinase A
-
Nesterova MV, Johnson N, Cheadle C, Bates SE, Mani S, Stratakis CA, Khan IU, Gupta RK, Cho-Chung YS. (2006). Autoantibody cancer biomarker: extracellular protein kinase A. Cancer Res 66:8971-4.
-
(2006)
Cancer Res
, vol.66
, pp. 8971-8974
-
-
Nesterova, M.V.1
Johnson, N.2
Cheadle, C.3
Bates, S.E.4
Mani, S.5
Stratakis, C.A.6
Khan, I.U.7
Gupta, R.K.8
Cho-Chung, Y.S.9
-
16
-
-
9144240010
-
DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway
-
Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T. (2004). DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23:8520-6.
-
(2004)
Oncogene
, vol.23
, pp. 8520-8526
-
-
Niida, A.1
Hiroko, T.2
Kasai, M.3
Furukawa, Y.4
Nakamura, Y.5
Suzuki, Y.6
Sugano, S.7
Akiyama, T.8
-
17
-
-
0029049759
-
Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma
-
Osaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K. (1995). Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest 108:157-62.
-
(1995)
Chest
, vol.108
, pp. 157-162
-
-
Osaki, T.1
Mitsudomi, T.2
Oyama, T.3
Nakanishi, R.4
Yasumoto, K.5
-
18
-
-
0032057466
-
p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors
-
Oyama T, Osaki T, Mitsudomi T, Ogawa R, Nakanishi R, Sugio K, Yasumoto K. (1998). p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors. Int J Mol Med 1:823-6.
-
(1998)
Int J Mol Med
, vol.1
, pp. 823-826
-
-
Oyama, T.1
Osaki, T.2
Mitsudomi, T.3
Ogawa, R.4
Nakanishi, R.5
Sugio, K.6
Yasumoto, K.7
-
19
-
-
0036839704
-
Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma
-
Ozaki Y, Kontani K, Hanaoka J, Chano T, Teramoto K, Tezuka N, Sawai S, Fujino S, Yoshiki T, Okabe H, Ohkubo I. (2002). Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 95:1954-62.
-
(2002)
Cancer
, vol.95
, pp. 1954-1962
-
-
Ozaki, Y.1
Kontani, K.2
Hanaoka, J.3
Chano, T.4
Teramoto, K.5
Tezuka, N.6
Sawai, S.7
Fujino, S.8
Yoshiki, T.9
Okabe, H.10
Ohkubo, I.11
-
20
-
-
0034767957
-
Cancer burden in the year 2000. The global picture
-
Parkin DM, Bray FI, Devesa SS. (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer 37 (Suppl. 8):S4-66.
-
(2001)
Eur J Cancer
, vol.37
, Issue.SUPPL. 8
-
-
Parkin, D.M.1
Bray, F.I.2
Devesa, S.S.3
-
21
-
-
20444475795
-
An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma
-
Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X, So S. (2005). An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 24:3737-47.
-
(2005)
Oncogene
, vol.24
, pp. 3737-3747
-
-
Patil, M.A.1
Chua, M.S.2
Pan, K.H.3
Lin, R.4
Lih, C.J.5
Cheung, S.T.6
Ho, C.7
Li, R.8
Fan, S.T.9
Cohen, S.N.10
Chen, X.11
So, S.12
-
22
-
-
33747468221
-
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation
-
Politou MC, Heath DJ, Rahemtulla A, Szydlo R, Anagnostopoulos A, Dimopoulos MA, Croucher PI, Terpos E. (2006). Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation. Int J Cancer 119:1728-31.
-
(2006)
Int J Cancer
, vol.119
, pp. 1728-1731
-
-
Politou, M.C.1
Heath, D.J.2
Rahemtulla, A.3
Szydlo, R.4
Anagnostopoulos, A.5
Dimopoulos, M.A.6
Croucher, P.I.7
Terpos, E.8
-
23
-
-
34548828781
-
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma
-
Qian J, Xie J, Hong S, Yang J, Zhang L, Han X, Wang M, Zhan F, Shaughnessy JD, Jr., Epstein J, Kwak LW, Yi Q. (2007). Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood 110:1587-94.
-
(2007)
Blood
, vol.110
, pp. 1587-1594
-
-
Qian, J.1
Xie, J.2
Hong, S.3
Yang, J.4
Zhang, L.5
Han, X.6
Wang, M.7
Zhan, F.8
Shaughnessy Jr., J.D.9
Epstein, J.10
Kwak, L.W.11
Yi, Q.12
-
24
-
-
0029024238
-
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung
-
Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, Sugarbaker DJ. (1995). Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 13:1265-79.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1265-1279
-
-
Strauss, G.M.1
Kwiatkowski, D.J.2
Harpole, D.H.3
Lynch, T.J.4
Skarin, A.T.5
Sugarbaker, D.J.6
-
25
-
-
0027842748
-
Different site mutation of the K-ras gene in a patient with metachronous double lung cancers
-
Sugio K, Inoue T, Inoue K, Yaita H, Inuzuka S, Ishida T, Sugimachi K. (1993). Different site mutation of the K-ras gene in a patient with metachronous double lung cancers. Anticancer Res 13:2469-71.
-
(1993)
Anticancer Res
, vol.13
, pp. 2469-2471
-
-
Sugio, K.1
Inoue, T.2
Inoue, K.3
Yaita, H.4
Inuzuka, S.5
Ishida, T.6
Sugimachi, K.7
-
26
-
-
0026654238
-
Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis
-
Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. (1992). Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 52:2903-6.
-
(1992)
Cancer Res
, vol.52
, pp. 2903-2906
-
-
Sugio, K.1
Ishida, T.2
Yokoyama, H.3
Inoue, T.4
Sugimachi, K.5
Sasazuki, T.6
-
27
-
-
25144483466
-
Autoantibody signatures in prostate cancer
-
Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. (2005). Autoantibody signatures in prostate cancer. N Engl J Med 353:1224-35.
-
(2005)
N Engl J Med
, vol.353
, pp. 1224-1235
-
-
Wang, X.1
Yu, J.2
Sreekumar, A.3
Varambally, S.4
Shen, R.5
Giacherio, D.6
Mehra, R.7
Montie, J.E.8
Pienta, K.J.9
Sanda, M.G.10
Kantoff, P.W.11
Rubin, M.A.12
Wei, J.T.13
Ghosh, D.14
Chinnaiyan, A.M.15
-
28
-
-
0026674937
-
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
-
Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP. (1992). Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52:4168-74.
-
(1992)
Cancer Res
, vol.52
, pp. 4168-4174
-
-
Winter, S.F.1
Minna, J.D.2
Johnson, B.E.3
Takahashi, T.4
Gazdar, A.F.5
Carbone, D.P.6
-
29
-
-
0037344296
-
Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors
-
Wirths O, Waha A, Weggen S, Schirmacher P, Kuhne T, Goodyer CG, Albrecht S, Von Schweinitz D, Pietsch T. (2003). Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest 83:429-34.
-
(2003)
Lab Invest
, vol.83
, pp. 429-434
-
-
Wirths, O.1
Waha, A.2
Weggen, S.3
Schirmacher, P.4
Kuhne, T.5
Goodyer, C.G.6
Albrecht, S.7
Von Schweinitz, D.8
Pietsch, T.9
-
30
-
-
34047270776
-
Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas
-
Yamabuki T, Takano A, Hayama S, Ishikawa N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Kondo S, Nakamura Y, Daigo Y. (2007). Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517-25.
-
(2007)
Cancer Res
, vol.67
, pp. 2517-2525
-
-
Yamabuki, T.1
Takano, A.2
Hayama, S.3
Ishikawa, N.4
Kato, T.5
Miyamoto, M.6
Ito, T.7
Ito, H.8
Miyagi, Y.9
Nakayama, H.10
Fujita, M.11
Hosokawa, M.12
Tsuchiya, E.13
Kohno, N.14
Kondo, S.15
Nakamura, Y.16
Daigo, Y.17
-
31
-
-
0029800165
-
Detection of autoantibodies against L-myc oncogene products in sera from lung cancer patients
-
Yamamoto A, Shimizu E, Ogura T, Sone S. (1996). Detection of autoantibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer 69:283-9.
-
(1996)
Int J Cancer
, vol.69
, pp. 283-289
-
-
Yamamoto, A.1
Shimizu, E.2
Ogura, T.3
Sone, S.4
-
32
-
-
0032998465
-
Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients
-
Yamamoto A, Shimizu E, Takeuchi E, Houchi H, Doi H, Bando H, Ogura T, Sone S. (1999). Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients. Oncology 56:129-33.
-
(1999)
Oncology
, vol.56
, pp. 129-133
-
-
Yamamoto, A.1
Shimizu, E.2
Takeuchi, E.3
Houchi, H.4
Doi, H.5
Bando, H.6
Ogura, T.7
Sone, S.8
-
33
-
-
0027457620
-
Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
-
Zweig MH, Campbell G. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-77.
-
(1993)
Clin Chem
, vol.39
, pp. 561-577
-
-
Zweig, M.H.1
Campbell, G.2
|